National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Dictionary of Cancer Terms

Page Options
Print This Page  Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Actimid (AK-tih-mid)

  A substance being studied in the treatment of prostate cancer, multiple myeloma, and other types of cancer. Actimid is a form of the drug thalidomide. It stops the growth of blood vessels, stimulates the immune system, and may kill cancer cells. Actimid is a type of angiogenesis inhibitor and a type of immunomodulatory agent. Also called CC-4047 and pomalidomide.

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov